Alyra Biotech is an early stage bio-pharmaceutical company with novel, first-in-class, neuroimmune modifying, Toll-Like Receptor inhibiting, intrauterine products to treat neuroimmune conditions, including pain, in women. Our products offer an entirely new approach to difficult to treat conditions with large global unmet human need. They utilize drugs with long term human safety data, including safety in pregnant females, to de-risk drug development. Alyra Biotech is guided by our close collaboration with consumers and end user research. Women are the center of our innovation process.